Canaccord Genuity Initiates Radius Health At Buy

Loading...
Loading...
Analysts at Canaccord Genuity initiated coverage on shares of Radius Health
RDUS
with a Buy rating. The target price for Radius Health is set to $21. Radius Health's shares dropped 2.57% to close at $12.14 yesterday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsCanaccord Genuity
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...